63.84
0.25 (0.39%)
| Previous Close | 63.59 |
| Open | 63.92 |
| Volume | 876,597 |
| Avg. Volume (3M) | 1,663,854 |
| Market Cap | 7,741,774,848 |
| Price / Earnings (TTM) | 20.53 |
| Price / Earnings (Forward) | 12.69 |
| Price / Sales | 0.650 |
| Price / Book | 2.32 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 3.21% |
| Operating Margin (TTM) | 5.75% |
| Diluted EPS (TTM) | 3.21 |
| Quarterly Revenue Growth (YOY) | -0.10% |
| Quarterly Earnings Growth (YOY) | 18.30% |
| Total Debt/Equity (MRQ) | 68.32% |
| Current Ratio (MRQ) | 1.38 |
| Operating Cash Flow (TTM) | 688.00 M |
| Levered Free Cash Flow (TTM) | 548.63 M |
| Return on Assets (TTM) | 4.61% |
| Return on Equity (TTM) | 8.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Mixed | Mixed |
| Medical Distribution (Global) | Bullish | Mixed | |
| Stock | Henry Schein, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 2.13 |
|
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Small Core |
| % Held by Insiders | 0.84% |
| % Held by Institutions | 107.70% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Palestra Capital Management Llc | 30 Jun 2025 | 3,501,520 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 83.00 (Evercore ISI Group, 30.01%) | Buy |
| Median | 77.00 (20.61%) | |
| Low | 70.00 (UBS, 9.65%) | Hold |
| Average | 76.75 (20.22%) | |
| Total | 3 Buy, 1 Hold | |
| Avg. Price @ Call | 66.20 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barrington Research | 22 Oct 2025 | 78.00 (22.18%) | Buy | 63.51 |
| 23 Sep 2025 | 78.00 (22.18%) | Buy | 69.21 | |
| Evercore ISI Group | 26 Aug 2025 | 83.00 (30.01%) | Buy | 69.06 |
| 06 Aug 2025 | 70.00 (9.65%) | Hold | 66.32 | |
| JP Morgan | 07 Aug 2025 | 76.00 (19.05%) | Buy | 65.90 |
| UBS | 06 Aug 2025 | 70.00 (9.65%) | Hold | 66.32 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 22 Oct 2025 | Announcement | Henry Schein to Participate in Upcoming Investor Conferences in November |
| 21 Oct 2025 | Announcement | Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET |
| 16 Oct 2025 | Announcement | Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. |
| 15 Oct 2025 | Announcement | The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide |
| 09 Sep 2025 | Announcement | Henry Schein Medical Expands SolutionsHub with Colaborate |
| 09 Sep 2025 | Announcement | Henry Schein Announces $750 Million Share Repurchase Plan |
| 22 Aug 2025 | Announcement | Henry Schein to Participate in Upcoming Investor Conferences in September |
| 19 Aug 2025 | Announcement | Henry Schein’s 28th Annual ‘Back to School’ Program Supports Students Worldwide |
| 05 Aug 2025 | Announcement | Henry Schein Reports Second Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |